Quintiles, Quest Diagnostics launch joint venture

On July 2nd 2015 Quintiles and Quest Diagnostics announced that they have launched their new global clinical trials lab services organization, Q² Solutions. It’s U.S. headquarters will be based in the Bradford Building at 5827 South Miami Blvd. in Durham.

Durham's Quintiles Expands

Durham's Quintiles has expanded, opening an office in Shanghai, China.

Quintiles Adds 300 With Acquisition

Biopharmaceutical research-giant Quintiles completed the acquisition of Encore Health Resources, a move that adds 300 workers and further expands the company’s services beyond strictly clinical work.

Quintiles Will Partner to Launch Marketing Analytics Platform

Pharmaceutical research organization Quintiles will partner with analytics group MMC to launch a new marketing analytics platform.

Quintiles Acquires Encore Health Resources

Quintiles will add 300 employees with a acquisition of Encore Health Resources, a Houston, Texas-based electronic health records  company.

Quintiles and Biogen Announce Partnership

Durham's Quintiles and Biogen, two biopharmaceutical companies with major presences in the region have announced a five-year collaboration agreement in order to improve Biogen's clinical development process.

Quintiles Receives Recognition as Leading Security Controls Company

Durham-based Quintiles, a pharmaceutical services provide has received recognition for its Cloud Services Model on the 2014 CSO40 as one of 40 leading companies in security controls, a list compiled by CSO magazine.

Quintiles New App Provides Medicine Warnings

Quintiles, a life science services company is providing patient warnings and reminders about medication through a new mobile app, MediGuard.

Quintiles Hires Commercial Services President

Durham's Quintiles has hired W. Scott Evangelista, an executive at Deloitte Consulting, to be president of Integrated Commercial Services.

Quintiles Wins Two Scrip Awards

Durham's Quintiles has receives the top "Contract Research Organization" honor for the second consecutive year at the annual Scrip Awards.

Quintiles Partners with Muscular Dystrophy Association

Quintiles, a Durham clinical research organization has partnered with the Muscular Dystrophy Associaiton to develop and implement the U.S. Neuromuscular Disease Registry.

Quintiles closes on Novella Clinical

Durham contract research organization Quintiles has closed on its acquisition of Morrisville-based Novella Clinical.

Quintiles Wins $1 M Research Grant

Quintiles has won a $1 million research grant to compare the effectiveness of treatments for uterine fibroids, a condition common among women of childbearing age.

Quintiles Stock Begins Trading on NYSE

Durham-based Quintiles announced that it will offer its common stock for purchase by the public at a price of $40 on Thursday, when its stock starts trading on the New York Stock Exchange.

Quintiles Set to Go Public May 10

Durham's Quintiles is set to go public on May 10 with a range of $36 to $40 per share, the $750 million deal would make Quintiles the third-largest IPO so far this year.

MetaMetrics Launches New Quantiles.com and Summer Math Challenge

MetaMetrics(R) , developer of The Quantile(R) Framework for Mathematics, released a new and improved version of its website Quantiles.com, which improves Quantile Framework. The Quantile Framework provides a way to describe a student's mathematical achievement and the difficulty of specific mathematical skills and concepts in order to better match a student with appropriate learning materials.

Quintiles Announces Contract with Bristol-Myers Squibb

Durham's Quintiles, a company that provides contract services for drug companies including management of clinical trials, has a five-year deal with the global biopharmaceutical company Bristol-Myers Squibb.

Quintiles Files to Go Public

Clinical testing company Quintiles Transnational wants to become a public company again after nearly a decade in private hands.

Quintiles Looking to go Public

Quintiles, the Durham-based private company that provides contract services to pharmaceutical companies, is looking to go public later this year, Bloomberg News reported Friday.

Quintiles partners with South Korea’s BioCore

Durham's Quintiles has signed a two-year partnership agreement with South Korean firm BioCore to provide its services to Quintiles exclusively. Financial terms of the deal with BioCore were not disclosed.